US 9056087
Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives
granted A61KA61K2039/505A61K38/2292
Quick answer
US patent 9056087 (Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERX BIOPHARMACEUTICALS, INC.
- Grant date
- Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K38/2292, A61P, A61P9/10